Exact Mass: 510.2412974

Exact Mass Matches: 510.2412974

Found 500 metabolites which its exact mass value is equals to given mass value 510.2412974, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Deuteroporphyrin IX

3-[20-(2-carboxyethyl)-5,9,14,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaen-4-yl]propanoic acid

C30H30N4O4 (510.226694)

Deuteroporphyrin IX is a non-natural dicarboxylic porphyrin. Deuteroporphyrins are porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. Deuteroporphyrin IX is described as a fecal porphyrin in patients with endemic chronic arsenic poisoning. (Environmental Sciences (Tokyo, Japan) (2001), 8(6), 561-570.). Excess accumulation of the biosynthetic intermediate protoporphyrin can lead to extensive tissue damage upon exposure to light since protoporpyhyrin is a potent photosensitizing agent, giving rise to membrane-destroying oxygen radicals or singlet oxygen. For instance, in the human porphyria disease porphyria variegata, a genetic deficiency in a heme biosynthetic enzyme, protoporphyrinogen oxidase, leads to protoporphyrin accumulation and lightdependent skin photosensitivity. Horseradish peroxidase (HRP) in the presence of glutathione (GSH) could oxidize the non-natural porphyrin deuteroporphyrin IX, which is closely related to protoporphyrin IX. The product is a unique green chlorin. One of the pyrrole rings had been modified by addition of an hydroxy and an oxo group, thus giving the characteristic reduced pyrrole ring of the chlorine. Of most importance for human medicine, peroxidative enzymes present in mammalian cells can also carry out these GSH-dependent oxidative conversions of protoporphyrin and deuteroporphyrin. (PMID: 10334939). Deuteroporphyrin IX is a non-natural dicarboxylic porphyrin. Deuteroporphyrins are porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. Deuteroporphyrin IX is described as a fecal porphyrin in patients with endemic chronic arsenic poisoning. (Environmental Sciences (Tokyo, Japan) (2001), 8(6), 561-570.)

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulfonyl]piperazin-1-yl)ethyl)quinazoline

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulphonyl]piperazin-1-yl)ethyl)quinazoline

C27H34N4O4S (510.23006440000006)

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R),2R,3S*))-

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-

C24H38N4O6S (510.2511928)

Deuteroporphyrin

3-[20-(2-carboxyethyl)-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),4,6,8,10,12,14,16,18(21),19-undecaen-4-yl]propanoic acid

C30H30N4O4 (510.226694)

PA(2:0/18:1(12Z)-2OH(9,10))

[(2R)-3-(acetyloxy)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}propoxy]phosphonic acid

C23H43O10P (510.2593708)

PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/2:0)

[(2R)-2-(acetyloxy)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}propoxy]phosphonic acid

C23H43O10P (510.2593708)

PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

3beta-Acetoxy-1-oxo-Delta8(9),14(15)-methylmelicat|Angustidienolid|Angustobidienolid

C29H34O8 (510.2253564)

ent-6,9-Dihydroxy-15-oxo-16-kauren-19-oic acid beta-D-glucopyranosyl ester

C26H38O10 (510.24648479999996)

Adenostemmoside B

C26H38O10 (510.24648479999996)

cantleyanone D

C29H34O8 (510.2253564)

sordaricin-1-beta-D-glucose ester

C26H38O10 (510.24648479999996)

orbiculin C

C29H34O8 (510.2253564)

FT-0672731

C29H34O8 (510.2253564)

Orthosiphol E

C29H34O8 (510.2253564)

6|A-Hydroxypaniculoside III

C26H38O10 (510.24648479999996)

cantleyanone B

C29H34O8 (510.2253564)

2alpha,16-dihydroxy-4beta-carboxy-O-beta-D-glucopyranosyl-19-nor-totarol

C26H38O10 (510.24648479999996)

andhraxylocarpin C

C29H34O8 (510.2253564)

astrogorgin G

C26H38O10 (510.24648479999996)

4beta,9alpha,20-trihydroxy-13,15-secotiglia-1,6-diene-3,13-dione 20-O-beta-D-glucopyranoside|euphopiloside A|[(3aR,6aS,7S,10R,10aR,10bS)-3,3a,4,6a,7,8,9,10,10a,10b-decahydro-3a,10a-dihydroxy-2,10-dimethyl-3,8-dioxo-7-(propan-2-yl)benzo[e]azulen-5-yl]methyl beta-D-glucopyranoside

4beta,9alpha,20-trihydroxy-13,15-secotiglia-1,6-diene-3,13-dione 20-O-beta-D-glucopyranoside|euphopiloside A|[(3aR,6aS,7S,10R,10aR,10bS)-3,3a,4,6a,7,8,9,10,10a,10b-decahydro-3a,10a-dihydroxy-2,10-dimethyl-3,8-dioxo-7-(propan-2-yl)benzo[e]azulen-5-yl]methyl beta-D-glucopyranoside

C26H38O10 (510.24648479999996)

granatumin K|methyl rel-(1R,6S,6aS,8R,9S,9aR,9bS,11aR,12R)-12-(acetyloxy)-1-(furan-3-yl)-1,3,6,6a,7,8,9,9a,9b,10,11,11a-dodecahydro-6a-hydroxy-8,9a,11a-trimethyl-3-oxo-6,8-methanocyclopenta[5,6]naphtho[2,1-c]pyran-9-acetate

granatumin K|methyl rel-(1R,6S,6aS,8R,9S,9aR,9bS,11aR,12R)-12-(acetyloxy)-1-(furan-3-yl)-1,3,6,6a,7,8,9,9a,9b,10,11,11a-dodecahydro-6a-hydroxy-8,9a,11a-trimethyl-3-oxo-6,8-methanocyclopenta[5,6]naphtho[2,1-c]pyran-9-acetate

C29H34O8 (510.2253564)

Manumycin B

C28H34N2O7 (510.2365894)

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

C26H38O10 (510.24648479999996)

orbiculin B

C29H34O8 (510.2253564)

6,7-dihydrofoliamenthoic acid 1-O-beta-D-glucopyranosyl ester-8-O-beta-D-glucopyranoside

C22H38O13 (510.2312298)

7beta-acetyl-6beta-benzoyl-12,16-epoxy-5alpha-hydroxy-12alpha-methoxycassa-12,15-dien-19beta-oic acid|pulcherrimin F

C29H34O8 (510.2253564)

10-Debenzoyl-2??-acetoxy-brevifoliol

C26H38O10 (510.24648479999996)

farnesiaside

C26H38O10 (510.24648479999996)

Paniculoside III

C26H38O10 (510.24648479999996)

(4aR,5R,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-6-(hydroxymethyl)-5,8a-dimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|17-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone 18-beta-D-glucopyranosyl ester|caseariaside B

(4aR,5R,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-6-(hydroxymethyl)-5,8a-dimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|17-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone 18-beta-D-glucopyranosyl ester|caseariaside B

C26H38O10 (510.24648479999996)

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

C26H38O10 (510.24648479999996)

Ile Thr Tyr Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid